Related by context. All words. (Click for frequent words.) 63 squamous cell carcinoma SCC 63 papillomas 62 nonmelanoma skin cancers 62 hyperplastic 61 osteosarcomas 61 basal cell carcinoma BCC 61 precursor lesions 60 basal cell carcinomas 60 Basal cell carcinoma 60 metastatic lesions 60 cutaneous squamous cell carcinoma 60 basal cell cancers 60 intestinal metaplasia 59 gastric adenocarcinoma 59 pulmonary metastases 59 leiomyomas 59 invasive carcinoma 59 lipomas 59 renal tumors 59 Gorlin syndrome 59 varices 59 malignant neoplasms 59 hypertrophic scars 59 nonmelanoma skin cancer 59 nonalcoholic steatohepatitis NASH 59 precancers 59 colorectal carcinoma 59 serous ovarian cancer 58 keratoses 58 epithelial tumors 58 cervical lymph nodes 58 urothelial carcinoma 58 solar keratoses 58 calculi 58 GISTs 58 nodular 58 Melanomas 58 hepatic metastases 58 adenocarcinomas 58 Mitomycin C 58 fibroadenomas 58 superficial basal cell carcinoma 58 keloid 58 RAS mutations 58 Surgical resection 58 neoplasia 58 malignant tissue 58 histologic subtype 57 osteochondromas 57 surgical excision 57 mupirocin 57 neoplasms 57 adenomatous polyps 57 bronchogenic carcinoma 57 acne vulgaris 57 Surgical excision 57 atrophic gastritis 57 malignant growths 57 HBeAg negative 57 neoplasm 57 candidemia 57 squamous cell carcinomas 57 cervical carcinoma 57 pituitary adenomas 57 seminomas 57 actinic keratosis 57 SCCs 57 Recurrences 57 ductal cancer 57 premalignant 57 bladder cancers 56 meningiomas 56 differentiated thyroid 56 malignant neoplasm 56 abnormal Pap smears 56 papillary 56 melanocytic nevi 56 indolent lymphomas 56 micrometastases 56 cutaneous melanoma 56 Benign tumors 56 skeletal metastases 56 corneal ectasia 56 Keloids 56 hamartomas 56 neoplastic 56 paragangliomas 56 invasive fungal infection 56 prostate adenocarcinoma 56 colon adenomas 56 Barrett esophagus BE 56 GnRH agonists 56 breast carcinoma 56 femoral neck fractures 56 metastatic neuroendocrine tumors 56 neoplasias 56 carcinoids 56 superficial bladder cancer 56 thyroid nodules 56 NMIBC 56 hepatocellular carcinomas 56 cytoreduction 56 papilloma 56 carcinomas 56 chronic GVHD 56 colonic polyps 56 rebleeding 56 Chlamydia trachomatis infection 56 HGPIN 55 advanced adenomas 55 colorectal liver metastases 55 Adenomas 55 solar keratosis 55 breast carcinomas 55 astrocytomas 55 infantile hemangiomas 55 MGUS 55 acute herpetic keratitis 55 histologic subtypes 55 urothelial cancer 55 metastatic bladder 55 benign polyps 55 metaplasia 55 HbF 55 adenomatous 55 bone metastasis 55 squamous cell cancers 55 polyposis 55 ADPKD 55 Basal cell 55 gastroduodenal 55 Actinic Keratosis 55 vascular lesions 55 PCa 55 colorectal neoplasms 55 acute GvHD 55 chronic HBV infection 55 anti angiogenic therapy 55 prostate carcinomas 55 CMV infection 55 seminoma 55 colorectal adenocarcinoma 55 GBMs 55 germline mutations 55 Gliomas 55 metastatic lymph nodes 55 gonococcal 55 carcinoma 55 hematopoietic malignancies 55 immunosuppressed patients 55 CIN2 + 55 T2 lesions 55 keloids 55 bacteriuria 55 colorectal metastases 55 renal cell carcinomas 55 benign nodules 55 leiomyoma 55 Squamous cell carcinomas 55 neuroblastomas 55 lesions 55 precancerous cervical lesions 55 colorectal cancer CRC 55 vWD 55 castrate resistant 54 gastric cancers 54 chromosomal rearrangement 54 neovascularisation 54 genital herpes infections 54 intra abdominal infections 54 nodal metastasis 54 LTBI 54 grade gliomas 54 proliferative diabetic retinopathy 54 lichen planus 54 CIN3 + 54 malignant lesions 54 paroxysmal AF 54 tumor metastases 54 hematologic toxicity 54 squamous 54 Candida infection 54 anterior uveitis 54 transarterial 54 situ CIS 54 pleural effusions 54 P. acnes 54 microscopic hematuria 54 LSIL 54 lobular 54 comedones 54 neoplastic lesions 54 DCIS lesions 54 actinic keratosis AK 54 hepatic metastasis 54 macroalbuminuria 54 ASCUS 54 distant metastases 54 diaper dermatitis 54 trichiasis 54 cranial irradiation 54 actinic keratoses 54 papular 54 Topical corticosteroids 54 ovarian carcinoma 54 HCV infections 54 endometrial cancers 54 pre malignant lesions 54 pyoderma 54 choroidal neovascularization 54 trans retinoic acid 54 lymphocytic 54 schwannomas 54 ductal 54 Papillary 54 medullary thyroid cancer 54 allogeneic HSCT 54 mycosis fungoides 54 cervical lesions 54 hyaluronic acid fillers 54 chronic HCV 54 dengue hemorrhagic fever DHF 54 SLNB 54 grade cervical intraepithelial 54 S. aureus infections 54 imiquimod 54 tumoral 54 S. aureus infection 54 enterococcal 54 CIN3 54 cytotoxic therapies 54 intravitreal injections 54 aphthous ulcers 54 hydrocele 54 S aureus 54 metachronous 54 benign lesions 54 ALT flares 54 lobular carcinoma 54 polypoid lesions 54 Venous thromboembolism 54 hematopoietic cancers 54 gynecological malignancies 54 dysplastic lesions 54 hepatocellular carcinoma HCC 54 basal cell nevus syndrome 54 Histologically 54 Metastatic breast cancer 54 photosensitizing agent 54 hypopigmentation 54 Gleevec resistant 54 papules 54 renal allograft 54 pleomorphic 54 Bleomycin 54 thrombi 54 vulvar intraepithelial neoplasia 54 neutropaenia 54 urethral strictures 54 lymphadenopathy 54 pathologic diagnosis 54 neuroendocrine cancers 54 Hurthle cell 54 GIST tumors 54 acne rosacea 54 benign neoplasms 54 Sezary syndrome 54 invasive ductal 54 nasal polyps 54 malignancies 54 node metastases 54 osteoblastic 54 radioiodine therapy 54 adenoma 54 TB MDR TB 54 resectable 54 elevated LDH 54 Polycythemia vera 54 prostate cancer CaP 54 systemic scleroderma 54 lymphocytosis 54 Radical prostatectomy 54 melasma 54 cystoscopic 54 hepatocellular cancer 54 N. gonorrhoeae 54 interstitial pneumonia 54 Adjuvant chemotherapy 53 ano genital warts 53 BSIs 53 repigmentation 53 gastrointestinal tumors GIST 53 Thyroid nodules 53 etiologic agent 53 NOMID 53 testicular cancers 53 malignant melanomas 53 oesophageal adenocarcinoma 53 nodular melanoma 53 Neoadjuvant chemotherapy 53 histologically 53 varicella infection 53 chlamydial infection 53 acne lesions 53 Acne Rosacea 53 subependymal giant cell 53 ALA PDT 53 infective endocarditis 53 thrombotic events 53 polypoid 53 Sjögren syndrome 53 perianal 53 malignant nodules 53 colorectal polyp 53 transitional cell carcinoma 53 liver metastases 53 biliary tract cancer 53 mutated K ras 53 ophthalmia 53 chronic periodontitis 53 urothelial 53 gastric cardia 53 multicentric 53 H pylori 53 Chronic lymphocytic leukemia 53 antiandrogen 53 osteoid osteoma 53 extracranial 53 adrenalectomy 53 ductal breast cancer 53 myoma 53 stem cell transplantations 53 histologies 53 Radiofrequency ablation 53 atypical hyperplasia 53 malignant pancreatic 53 Tumours 53 imiquimod cream 53 diagnostic modality 53 mediastinitis 53 invasive ductal carcinoma 53 enucleation 53 proctitis 53 postoperative infection 53 Uterine fibroids 53 malignant lymphoma 53 malignant pleural mesothelioma 53 chemotherapeutic regimens 53 invasive candidiasis 53 CTEPH 53 antiandrogens 53 seborrheic keratoses 53 biliary strictures 53 eccrine 53 radionuclide therapy 53 Squamous cell 53 hemorrhagic complications 53 moderately emetogenic 53 Postoperative complications 53 noninfectious uveitis 53 colorectal carcinomas 53 immunocompetent 53 inoperable tumors 53 adjunctively 53 Squamous 53 bacteraemia 53 ALCL 53 cervical intraepithelial neoplasia 53 ESBLs 53 invasive ductal breast cancer 53 dosage regimens 53 hydronephrosis 53 plasminogen activators 53 radiochemotherapy 53 pyelonephritis 53 dysplastic 53 mycobacterial infections 53 endoleaks 53 geographic atrophy 53 Neoplasms 53 prostate carcinoma 53 colorectal adenoma 53 metastatic renal 53 peritoneal carcinomatosis 53 neoadjuvant therapy 53 Zyclara Cream 53 Latent TB 53 Medullary thyroid cancer 53 haemorrhagic 53 Candida infections 53 abnormal pap smears 53 keloid scars 53 HER2 overexpression 53 ocular toxicity 53 embryonal rhabdomyosarcoma 53 anti angiogenic agents 53 pulmonary nodules 53 sclerosing 53 fibroma 53 liver metastasis 53 angiographically 53 Herpes zoster 53 radiographic findings 53 grade dysplasia 53 carotid stenosis 53 Meningiomas 53 staphylococcal infections 53 transurethral resection 53 malignant phenotype 53 Helicobacter pylori infection 53 hyperplastic polyps 53 cell carcinomas 53 adenomatous polyp 53 therapeutic regimens 53 osteoid 53 cytotoxic chemotherapy 53 HSV1 53 neurological manifestations 53 plexiform neurofibromas 53 seborrheic dermatitis 53 trans retinoic acid ATRA 53 indolent NHL 53 risk reducing salpingo 53 simplex virus 53 gastrointestinal adverse reactions 53 molluscum contagiosum 53 Prostatitis 53 completely resected 53 variceal 53 abnormal cytology 52 basal cell skin 52 SSc 52 S. aureus bacteria 52 lymphadenectomy 52 axilla 52 granulomas 52 contralateral breast 52 TRUS biopsy 52 ductal carcinomas 52 Glioblastomas 52 orchitis 52 chronic rhinosinusitis 52 somatic mutations 52 urolithiasis 52 tibial plateau fractures 52 oropharyngeal candidiasis 52 C. trachomatis 52 post thrombotic syndrome 52 cell carcinoma 52 malignant tumors 52 uveal melanoma 52 urothelial bladder cancer 52 Acute myeloid leukemia 52 pelvic lymphadenectomy 52 benign growths 52 Trichomonas vaginalis 52 polyps growths 52 mesotheliomas 52 Onychomycosis 52 postoperative infections 52 myelomas 52 external beam radiotherapy 52 opacification 52 malignant ovarian 52 cytoreductive nephrectomy 52 thyrotoxicosis 52 histological subtype 52 renal pelvis 52 esophageal cancers 52 genital wart 52 HPV subtypes 52 advanced neoplasia 52 Endometrial cancer 52 lung carcinomas 52 coagulase negative staphylococci 52 squamous cell cancer 52 malignant lesion 52 methicillin susceptible Staphylococcus aureus 52 cystic lesions 52 ocular melanoma 52 pre cancerous lesion 52 VUR 52 intraoperative complications 52 malignancy 52 tumors 52 nonmelanoma 52 Hypertrophic 52 sarcomatoid 52 pulmonary dysfunction 52 myelodysplastic myeloproliferative diseases 52 clinically detectable 52 recurrent GBM 52 soft tissue sarcomas 52 metastatic tumors 52 hypereosinophilic syndrome 52 receptor tyrosine kinase inhibitor 52 lesional 52 poliovirus vaccine 52 tuberous sclerosis TS 52 immunosuppressives 52 urethritis 52 basal cell 52 granulomatous 52 pheochromocytoma 52 thrombolytic agents 52 Brain metastases 52 Clostridium difficile infections 52 lipid lowering agents 52 Genital warts 52 Cysts 52 oncologic outcomes 52 nonproliferative 52 sonographic appearance 52 lobular carcinomas 52 lymph node dissection 52 invasive fungal infections 52 herpesviruses 52 chest radiograph 52 antiseptic chlorhexidine 52 cephalosporin antibiotics 52 atrophic 52 invasive carcinomas 52 ureteral obstruction 52 Aspergillus infections 52 gene rearrangements 52 Anaplastic 52 neoplastic diseases 52 cystoid macular edema 52 intravenous bisphosphonates 52 mucinous 52 follicular lymphoma 52 empyema 52 aortic dissections 52 pre cancerous actinic 52 esotropia 52 benign prostatic hypertrophy 52 PAOD 52 S.aureus 52 melanocytic 52 pancreatic NET 52 Renal cell carcinoma 52 recurrent glioblastoma multiforme GBM 52 molecularly defined 52 lacunar 52 streptococcal infections 52 cholangiocarcinoma 52 biliary stones 52 premalignant lesions 52 tumor nodules 52 pulmonary hypertension PH 52 total thyroidectomy 52 ALK mutations 52 sacral neuromodulation 52 thromboembolic disease 52 nasopharyngeal cancer 52 PNET 52 HPV infections 52 radical nephrectomy 52 pedicle screw fixation 52 T1D 52 primary hyperparathyroidism 52 relapsed ovarian cancer 52 rhinosinusitis 52 Keratitis 52 non Hodgkin lymphomas 52 thyroid carcinomas 52 Abscesses 52 bullous 52 Combination therapy 52 metastases 52 HPVs 52 thoracoscopic lobectomy 52 grade cervical dysplasia 52 concurrent chemoradiation 52 cancers 52 Chlamydia trachomatis 52 colonoscopic 52 cortical dysplasia 52 microbial keratitis 52 varicocele 52 Sentinel node biopsy 52 osteolytic 52 multimodality therapy 52 infarcts 52 systemic fungal infections 52 chemoradiation therapy 52 carotid plaques 52 haematological malignancies 52 anemias 52 locoregional recurrence 52 Hepatocellular Carcinoma HCC 52 vitreous hemorrhage 52 cancerous growths 52 precancerous cervical 52 thyroid nodule 52 vesicoureteral reflux 52 anogenital warts 52 thymectomy 51 untreated celiac disease 51 anaplastic 51 intestinal polyps 51 carcinoid tumors 51 resections 51 mutated KRAS gene 51 herpes labialis 51 endometrial carcinoma 51 IBS C 51 preoperative chemotherapy 51 leukoencephalopathy 51 Intestinal parasites 51 venous blood clots 51 granulosa cell 51 mammographically 51 carcinoid 51 lymphoid 51 mycophenolate 51 lung adenocarcinomas 51 breast abscesses 51 ethambutol 51 neuroblastoma tumors 51 cytoreductive surgery 51 intravesical therapy 51 leukaemias 51 atopic dermatitis AD 51 Squamous Cell Carcinoma 51 liver resection 51 CD4 + T lymphocytes 51 Genital herpes 51 griseofulvin 51 lung metastases 51 Pancreatic neuroendocrine tumors 51 Chronic pancreatitis 51 aerodigestive tract 51 precancer 51 corneal infections 51 Lymphocytic 51 cytomegalovirus infection 51 microscopic colitis 51 antiangiogenic therapy 51 prognostic variables 51 genital tract infections 51 intracavitary 51 IFNs 51 suppurative 51 neuroendocrine carcinoma 51 Chronic Prostatitis 51 Malignant tumors 51 osteoporotic compression fractures 51 purpura 51 symptomatic paroxysmal AF 51 neutropenic patients 51 Aortic aneurysms 51 neurologic complications 51 malignant prostate 51 GABHS 51 MALT lymphoma 51 herpetic 51 esophagogastric 51 LRTI 51 antibiotics metronidazole 51 transthyretin amyloidosis 51 neutropenic 51 bullae 51 asplenia 51 recurrent glioblastoma 51 supratentorial 51 MMP inhibitors 51 choriocarcinoma 51 prostatic 51 brain metastases 51 perfusion abnormalities 51 Synovial sarcoma 51 Extensively drug 51 candidiasis 51 cystectomy 51 benign uterine 51 precancerous polyp 51 childhood leukemias 51 basal cell cancer 51 sarcomas 51 hepatoma 51 gastric corpus 51 sentinel nodes 51 T1a 51 axillary lymph node dissection 51 dysplastic nevi 51 UPPP 51 incidentalomas 51 skin sparing mastectomy 51 fungoides 51 focally 51 neuroendocrine tumors 51 polypectomy 51 benign breast 51 incisional hernias 51 microfilariae 51 ß blockers 51 fluoroquinolone resistance 51 Follicular lymphoma 51 iritis 51 causative organism 51 erythema redness 51 P. vivax malaria 51 vaginitis 51 hemorrhagic cystitis 51 oral NSAIDs 51 esophageal tumors 51 fibroadenoma 51 chronic urticaria 51 oesophageal 51 tract infections 51 papillary renal cell carcinoma 51 upper gastrointestinal bleeding 51 gonorrhoeae 51 BRAF mutations 51 acoustic neuromas 51 immunocompetent patients 51 thrombotic complications 51 FluCAM arm 51 submandibular gland 51 CMV disease 51 histopathologic examination 51 HCV infection 51 P. falciparum malaria 51 pT2 51 Atopic dermatitis 51 pediatric acute lymphoblastic 51 adenomyosis 51 tumor subtypes 51 fragility fractures 51 post herpetic neuralgia 51 metastatic malignant melanoma 51 K#N 51 nonmetastatic 51 cell lymphomas 51 axillary lymph nodes 51 erythema nodosum 51 paraganglioma 51 recurrent genital herpes 51 Toxicities 51 Heavy menstrual bleeding 51 atherothrombotic 51 gonococcal infections 51 CMV retinitis 51 sCJD 51 AV fistulas 51 postoperative atrial fibrillation 51 Benign breast 51 varicoceles 51 Chronic lymphocytic leukemia CLL 51 HBV carriers 51 prostate cancer PCa 51 Melasma 51 Hemangiomas 51 genital HPV infection 51 invasive aspergillosis 51 pilocytic astrocytomas 51 mRCC 51 acute otitis media 51 bladder tumors 51 Glioblastoma Multiforme GBM 51 lung nodules 51 sulfasalazine 51 pre cancerous lesions 51 Acute lymphoblastic leukemia 51 TMPRSS2 ERG fusion 51 bone grafting procedures 51 conjunctival hyperemia 51 myeloproliferative diseases 51 cytological 51 percutaneous drainage 51 keratosis 51 Streptococcus pyogenes 51 ischemic lesions 51 pancreatic adenocarcinoma 51 serrated polyps 51 thromboses 51 inguinal hernia repair 51 monogenic 51 postoperative morbidity 51 idiopathic myelofibrosis 51 antimuscarinic 51 ablative lasers 51 mTOR inhibitors 51 prostatic tissue 51 pharmacologic intervention 51 ovarian tumors 51 bleomycin 51 Chronic sinusitis 51 generalized tonic clonic seizures 51 fluconazole resistant 51 hormone refractory 51 sarcoids 51 needleless connectors 51 metastatic melanomas 51 Catheter ablation 51 nevi 51 submucosa 51 Chlamydia infection 51 Propionibacterium acnes 51 pneumococcal infection 51 myeloproliferative neoplasms 51 gastrointestinal stromal tumors GIST 51 extracapsular extension 51 mycophenolate mofetil 51 excisional 51 lymphatic tissue 51 adenocarcinoma 51 fallopian tube carcinoma 51 asymptomatic carriers 51 adjunctive therapies 51 chemosensitivity 51 carbapenem resistant 51 chromophobe 51 chest radiography 51 prostate TURP 51 ofloxacin 51 mesenteric 51 locoregional 51 relapsing remitting 51 Severe Primary IGFD 50 staphylococci 50 eosinophilic 50 molluscum 50 Chronic Fatigue Syndrome CFS 50 carcinomatosis 50 cancerous polyps 50 endophthalmitis 50 pCR 50 androgen deprivation 50 debulking surgery 50 hepatic lesions 50 histologically proven 50 penetrance 50 femoral neck fracture 50 tumor recurrence 50 duplex ultrasonography 50 stage IIIB 50 Candidiasis 50 choroidal neovascularization CNV 50 gadolinium enhanced 50 infiltrating ductal carcinoma 50 guaiac 50 molecular abnormalities 50 PEP# [003] 50 Nodules 50 tonsillar 50 genital lesions 50 GI bleeds 50 cervical lymph node 50 cancerous enlargement 50 EBRT 50 wedge resection 50 anal canal 50 anatomic structures 50 bacterial sepsis 50 adrenocortical cancer 50 adjuvant therapies 50 bowel cancers 50 TNF blocker therapy 50 BRAF mutation 50 deletion 5q 50 skin abscesses 50 sentinel lymph nodes 50 quinolone 50 necrotizing 50 cisplatin chemotherapy 50 K ras mutations 50 gastrointestinal cancers 50 GBM tumors 50 melanomas 50 neovascularization 50 effector function 50 extrapulmonary 50 chlamydial 50 uninfected mice 50 papillary carcinoma 50 sentinel lymph node biopsy 50 T1DM 50 histologic examination 50 ANCA associated 50 amenorrhoea 50 squamous cell lung cancer 50 androgenetic alopecia 50 malignant lymphomas 50 P aeruginosa 50 neurofibromas 50 Fibroid tumors 50 cerebrovascular accidents 50 hypervascular 50 viral conjunctivitis 50 somatoform disorders 50 anticancer therapy 50 Phacoemulsification 50 esophageal gastric 50 deep vein thromboses 50 Acanthamoeba 50 thyroid carcinoma 50 inflammatory acne 50 cervicitis 50 Herniated discs 50 trochanteric bursitis 50 malignant polyps 50 CP CPPS 50 tumor xenograft models 50 melanoma lesions 50 CIN2 50 endometrial hyperplasia 50 benign tumors 50 renal scarring 50 herpes zoster 50 pre cancerous growths 50 etiologic factors 50 oropharyngeal cancers 50 perioperative complications 50 LRAT 50 papillary RCC 50 Chlamydia pneumoniae 50 vaginal yeast infections 50 donor cornea 50 mesangial 50 oxacillin 50 systemic amyloidosis 50 vesicoureteral reflux VUR 50 myofascial pain syndrome 50 arthropathy 50 neovascular glaucoma 50 lentigo maligna 50 lymph node enlargement 50 EGFR inhibitors 50 tumor necrosis 50 bronchiectasis 50 Enterococcus faecium 50 noninflammatory 50 corticosteroid therapy 50 SCCHN 50 opportunistic pathogens 50 recurrent VTE 50 pericardial effusion 50 topical corticosteroids 50 anemia neutropenia 50 mammary cancers 50 squamous cell skin 50 sarcoid 50 Lipsovir ® 50 hypoperfusion 50 HER2 positive cancers 50 non metastatic osteosarcoma 50 BPH LUTS 50 T. pallidum 50 allograft rejection 50 Acoustic neuromas 50 metastatic prostate 50 colorectal polyps 50 papule 50 EGFR tyrosine kinase inhibitors 50 radiofrequency ablation RFA 50 follicular thyroid cancer 50 MICs 50 CYT# potent vascular disrupting 50 LHRH antagonists 50 rectovaginal 50 convenient dosing regimens 50 hyperoxaluria 50 lymphoproliferative disorders 50 Methicillin 50 colorectal tumors 50 nephron sparing surgery 50 BPS IC 50 Embozene TM Microspheres 50 extranodal 50 epithelioid 50 ICSs 50 pulmonary resection 50 haematologic 50 Enterobacteriaceae 50 ovarian malignancy 50 axillary dissection 50 Necrotizing fasciitis 50 IL 1ß 50 heterotopic ossification 50 Degenerative Disc Disease 50 T1c 50 biliary obstruction 50 Cerashield TM 50 cIAI 50 recurrent bladder 50 Adhibit 50 urine cytology 50 quinolone antibiotics 50 choroidal 50 NNRTI resistance 50 lobular cancer 50 nephrogenic 50 antifungal medications 50 ependymomas 50 postoperative chemotherapy 50 clade B 50 NP CRNs